fda

Ignite It
3 min read • December 3, 2021

Bipartisan Bill Urges FDA To Regulate Hemp-Derived CBD Foods, USDA Amends Hemp Insurance Coverage

Ignite It
3 min read • December 2, 2021

AOC, GOP Congressman’s New Marijuana Bill Seeks State-Level Cannabis Expungements

Ignite It
2 min read • November 8, 2021

VA Rejects Cannabis Research As Veterans Plead For Medical Cannabis

Ignite It
3 min read • November 1, 2021

Report: CBD Content on Labels Differs From Levels Found in Actual Products

Ignite It
2 min read • October 20, 2021

FDA Will Use Reddit To Learn More About Cannabis-Derived Products Including CBD And Delta 8

Ignite It
3 min read • October 13, 2021

Lexaria Bioscience Reports Recent Oral THC Absorption Study Revealed Its DehydraTECH Required 15 Mins. To Deliver THC Levels In Blood Plasma

Ignite It
4 min read • September 22, 2021

MyMD Pharmaceuticals Announces Data It Says Demonstrates 8,000 Times Higher Potency Of Novel Synthetic Supera-CBD Over Plant-Derived CBD; Shares Move Higher

Ignite It
3 min read • September 14, 2021

FDA And CDC Issue Warnings On Hemp-Derived Products Containing Delta-8 THC

Ignite It
2 min read • September 14, 2021

From Cannabis MSO To Drug Development: Goodness Growth Wants To Understand Traditional Psychedelics Use

Ignite It
3 min read • September 8, 2021

Applied DNA Enters Into Master Services Agreement With Flora Growth For Cannabis Validation And Authentication, Secures First Statement Of Work Contract

Ignite It
3 min read • August 4, 2021

Cannabis Research Turns Up In Bipartisan Infrastructure Bill, Would Allow Scientists To Use Marijuana From Dispensaries

Ignite It
3 min read • July 8, 2021

Enveric Biosciences Reports Approval From Israel’s Ministry Of Health To Begin Phase 1/2 Trial Of Triple-Combo CBD Treatment For Glioblastoma

Browse By Channels

 After-Hours Center
 Analyst Color
 Analyst Ratings
 Andy Barr
 Asia
 Asset Sales
 Be Your Own Boss
 Binary Options
 Biotech
 Bonds
 Broad U.S. Equity ETFs
 Buybacks
 california cannabis
 Cannabis
 cannabis earnings
 cannabis farms
 cannabis study
 Christopher Dillis
 CNBC
 Commodities
 Congress cannabis
 Congress hemp
 Contracts
 Crowdsourcing
 Cryptocurrency
 Currency ETFs
 Dividends
 Downgrades
 Earnings
 Earnings Beats
 Earnings Misses
 Econ #s
 Economics
 Education
 Emerging Market ETFs
 Emerging Markets
 Entertainment
 Entrepreneurship
 Equities
 ESG
 ETFs
 Eurozone
 Events
 Exclusives
 Fast Money
 FDA
 Federal Reserve
 Financial Advisors
 Financing
 Fintech
 first quarter earnings
 Forex
 Futures
 Gaming
 General
 Global
 Government
 Guidance
 Health Care
 Hedge Funds
 hemp bill
 hemp legalization
 hemp regulation
 Hot
 illegal cannabis farms
 Initiation
 Insider Trades
 Insurance
 Interview
 intoxicating hemp-derived products
 Intraday Update
 IPOs
 James Comer
 Large Cap
 Latin America
 Legal
 Long Ideas
 M&A
 Macro Economic Events
 Macro Notification
 Management
 marijuana
 Market Summary
 Market-Moving Exclusives
 Markets
 Media
 Mid Cap
 Movers
 Movers & Shakers
 New ETFs
 News
 Offerings
 Opinion
 Options
 Penny Stocks
 Personal Finance
 Politics
 Pre-Market Outlook
 Press Releases
 Previews
 Price Target
 Psychedelics
 Psychology
 Real Estate
 Regulations
 REIT
 Reiteration
 Rescheduling
 Restaurants
 Retail Sales
 Reviews
 Rumors
 SEC
 Sector ETFs
 Short Ideas
 Short Sellers
 Signals
 Small Business
 Small Cap
 Small Cap Analysis
 Social Media
 Specialty ETFs
 Sports
 Sports Betting
 Startups
 Stock Split
 Success Stories
 Taxes
 Tech
 Technicals
 THC
 Top Stories
 Topics
 Trading Ideas
 Travel
 UC Berkeley Cannabis Research Center
 unlicensed cannabis
 Upgrades
 WIIM

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.